BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32669614)

  • 21. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.
    Yadav A; Kumar B; Datta J; Teknos TN; Kumar P
    Mol Cancer Res; 2011 Dec; 9(12):1658-67. PubMed ID: 21976712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.
    Wang D; Shen Q; Chen YQ; Wang MH
    Oncogene; 2004 Mar; 23(9):1668-80. PubMed ID: 15001985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SRSF2 promotes splicing and transcription of exon 11 included isoform in Ron proto-oncogene.
    Moon H; Cho S; Loh TJ; Oh HK; Jang HN; Zhou J; Kwon YS; Liao DJ; Jun Y; Eom S; Ghigna C; Biamonti G; Green MR; Zheng X; Shen H
    Biochim Biophys Acta; 2014 Nov; 1839(11):1132-40. PubMed ID: 25220236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
    J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma.
    Jiang C; Cheng Z; Jiang T; Xu Y; Wang B
    Genes Genomics; 2020 Aug; 42(8):971-978. PubMed ID: 32648233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression.
    Beauvais DM; Nelson SE; Adams KM; Stueven NA; Jung O; Rapraeger AC
    J Biol Chem; 2022 Jun; 298(6):102029. PubMed ID: 35569509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
    Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
    Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of hnRNPA2B1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer.
    Yang Y; Wei Q; Tang Y; Yuanyuan Wang ; Luo Q; Zhao H; He M; Wang H; Zeng Q; Lu W; Xu J; Liu T; Yi P
    Cancer Lett; 2020 Apr; 475():43-52. PubMed ID: 32006618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.
    Jiang F; Tang X; Tang C; Hua Z; Ke M; Wang C; Zhao J; Gao S; Jurczyszyn A; Janz S; Beksac M; Zhan F; Gu C; Yang Y
    J Hematol Oncol; 2021 Apr; 14(1):54. PubMed ID: 33794982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma.
    Wu D; Cheng J; Sun G; Wu S; Li M; Gao Z; Zhai S; Li P; Su D; Wang X
    Oncotarget; 2016 Jun; 7(24):36539-36550. PubMed ID: 27174914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel splicing variants of recepteur d'origine nantais (RON) tyrosine kinase involving exons 15-19 in lung cancer.
    Krishnaswamy S; Mohammed AK; Amer OE; Tripathi G; Alokail MS; Al-Daghri NM
    Lung Cancer; 2016 Feb; 92():41-6. PubMed ID: 26775595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the splice variants of Recepteur d'Origine nantais (RON) in lung cancer cell lines.
    Krishnaswamy S; Bukhari I; Mohammed AK; Amer OE; Tripathi G; Alokail MS; Al-Daghri NM
    Gene; 2018 Dec; 679():335-340. PubMed ID: 30223007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HNRNPA2B1 regulates the epithelial-mesenchymal transition in pancreatic cancer cells through the ERK/snail signalling pathway.
    Dai S; Zhang J; Huang S; Lou B; Fang B; Ye T; Huang X; Chen B; Zhou M
    Cancer Cell Int; 2017; 17():12. PubMed ID: 28077929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
    Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
    J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of anti-tumoral feedback loop between VHLα and hnRNPA2B1 in renal cancer.
    Liu Y; Zhang H; Li X; Zhang C; Huang H
    Cell Death Dis; 2020 Aug; 11(8):688. PubMed ID: 32826868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linc01232 promotes the metastasis of pancreatic cancer by suppressing the ubiquitin-mediated degradation of HNRNPA2B1 and activating the A-Raf-induced MAPK/ERK signaling pathway.
    Meng LD; Shi GD; Ge WL; Huang XM; Chen Q; Yuan H; Wu PF; Lu YC; Shen P; Zhang YH; Cao SJ; Miao Y; Tu M; Jiang KR
    Cancer Lett; 2020 Dec; 494():107-120. PubMed ID: 32814086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
    You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
    BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasis.
    Chou YC; Chen CL; Yeh TH; Lin SJ; Chen MR; Doong SL; Lu J; Tsai CH
    Am J Pathol; 2012 Nov; 181(5):1773-81. PubMed ID: 22974584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.
    Hu Y; Sun Z; Deng J; Hu B; Yan W; Wei H; Jiang J
    Tumour Biol; 2017 Mar; 39(3):1010428317694318. PubMed ID: 28351333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.
    Thangasamy A; Rogge J; Ammanamanchi S
    J Biol Chem; 2009 May; 284(21):14001-10. PubMed ID: 19307182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.